NCT06708962

Brief Summary

The aim of the study is to determine the effect of mulligan's mobilization on shoulder range of motion and subacromial joint space in paraplegic patients with subacromial impingement so, thirty patients will be randomly assigned to two groups group (A) and Group (B)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 25, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 29, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2025

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2025

Completed
Last Updated

February 12, 2025

Status Verified

February 1, 2025

Enrollment Period

2 months

First QC Date

November 25, 2024

Last Update Submit

February 10, 2025

Conditions

Paraplegia, Incomplete

Keywords

Range of motionsubacromial impingement

Outcome Measures

Primary Outcomes (1)

  • Shoulder joint range of motion

    Shoulder joint ROM ( flexion - abduction- external and internal rotation will be measured by The laser goniometer HALO

    Two months

Secondary Outcomes (1)

  • Subacromial joint space

    Two months

Study Arms (2)

Group A

ACTIVE COMPARATOR

Will receive mulligan's mobilization plus corticosteroid injection for shoulder joint

Other: Mulligan's mobilizationOther: corticosteroid injection for rotator cuff tendinopathy

corticosteroid injection for rotator cuff tendinopathy only

SHAM COMPARATOR

patients will receive corticosteroid injection for rotator cuff muscle only which helps in resolving inflammation at the shoulder joint

Other: corticosteroid injection for rotator cuff tendinopathy

Interventions

Mulligan's mobilizationOTHER

Mulligan mobilization isthe concurrent application of sustained accessory mobilization applied by a therapist and an active physiological movement to end range applied by the patient.

Group A
corticosteroid injection for rotator cuff tendinopathyOTHER

corticosteroid injection for rotator cuff helps resolving inflammation which occur for paraplegic patients from overuse of the crutches

Group Acorticosteroid injection for rotator cuff tendinopathy only

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • More than one year after traumatic spinal cord injury
  • The injury is at the second thoracic level or below.
  • No cognitive impairment
  • Relying on manual wheelchair for main movement.

You may not qualify if:

  • No frozen shoulder
  • No subluxation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Modern University for Technology and Information

Cairo, Egypt

Location

Related Links

MeSH Terms

Conditions

ParaplegiaShoulder Impingement Syndrome

Interventions

Adrenal Cortex Hormones

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsJoint DiseasesMusculoskeletal DiseasesShoulder InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

HormonesHormones, Hormone Substitutes, and Hormone Antagonists

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer at Basic Science Department

Study Record Dates

First Submitted

November 25, 2024

First Posted

November 29, 2024

Study Start

December 1, 2024

Primary Completion

January 30, 2025

Study Completion

February 10, 2025

Last Updated

February 12, 2025

Record last verified: 2025-02

Locations

EG(1)